Publication
Market Access for Gene Therapies
Strategic challenges and best practice: Our exclusive white paper provides profound insights into the recent developments of the gene therapy market.
Services
The Market Access Special Forces
As partners of our internationally operating clients, we support the successful market access especially of treatments for rare diseases, of ATMPs or of products which set new therapy standards, both on a strategic and operational level. We dedicate our enthusiasm to solving complex problems. 
Clients
Creating value in health care
"A unique combination of deep understanding of the matter, strategic vision, didactic skill and humor."

Founder and CEO of medical-technology company

What drives usOur insights

Event
Web Summit 2021
1st to 4th of Nov 2021
Prof. Matthias P. Schönermark, M.D., Ph.D.

Meet us at the world's largest tech conference.

more
 

What we doOur services

Value dossier
A successful benefit assessment with a convincing value story
 
Market Intelligence
Strategic, hypothesis-based analysis of market potentials and business opportunities
Strategic Pricing
Define balanced prices in a complex reference price environment
 
Benefit Assessment (AMNOG, medical devices)
Early identification of HTA challenges and strategic thinking
Market Access Strategy
Development of optimal strategies for a successful and sustainable market entry
 
Mobilizing the market
Identifying, activating and integrating all relevant stakeholders
Digital Health Applications (DiGA)
 

Whom we supportOur clients

How we workOur case studies

to the top